In this week's episode, we’ll learn more about the identification and characterization of stem cell-like leukemia blasts using single cell multi-omics, cyclophosphamide as a treatment for non-immune effector cell-associated neurotoxicity in patients treated with B-cell maturation antigen, or BCMA, targeted CAR T-cell therapies, and how differences in glycosylation affect the clearance of human plasma-derived and recombinant von Willebrand factor concentrates.
Featured Articles:
View all episodes
By American Society of Hematology
4.1
4949 ratings
In this week's episode, we’ll learn more about the identification and characterization of stem cell-like leukemia blasts using single cell multi-omics, cyclophosphamide as a treatment for non-immune effector cell-associated neurotoxicity in patients treated with B-cell maturation antigen, or BCMA, targeted CAR T-cell therapies, and how differences in glycosylation affect the clearance of human plasma-derived and recombinant von Willebrand factor concentrates.
Featured Articles:
11,155 Listeners
139 Listeners
318 Listeners
499 Listeners
75 Listeners
26 Listeners
1,156 Listeners
2 Listeners
363 Listeners
372 Listeners
1 Listeners
48 Listeners
189 Listeners
30 Listeners
4 Listeners